New drug may ease painful mouth sores for head and neck cancer patients
NCT ID NCT03387774
First seen May 27, 2026 · Last updated Jun 12, 2026 · Updated 4 times
Summary
This study tested whether ulinastatin, a drug that blocks certain enzymes, can lower the chance of severe mouth sores in people with advanced nasopharyngeal cancer receiving chemotherapy and radiation. 179 participants were randomly assigned to receive either standard care plus ulinastatin or standard care alone. The main goal was to see if fewer patients in the ulinastatin group developed painful mouth sores that interfere with eating.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORAL MUCOSITIS (ULCERATIVE) DUE TO RADIATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cancer Center, Sun Yat-sen University
Guangzhou, Guangdong, China
Conditions
Explore the condition pages connected to this study.